# V6_C11 LIVE MEDICAL CORPUS EXPANSION

## Corpus Validation Report

**Overall C11 Status: COMPLETE**

The Live Medical Corpus has been expanded to support a broader set of representative pharmacology and adverse drug event queries without contaminating the formal research evaluation boundary.

### Expansion Summary
- **Baseline V1 Size**: 5 documents, 5 chunks
- **Final V2 Size**: 14 documents, 14 chunks
- **Corpus Versioning**: Preserved V1 (`LIVE_MEDICAL_CORPUS_V1.json`); created `LIVE_MEDICAL_CORPUS_V2.json`.
- **Source Inventory**: Synthesized controlled representations from `DAILYMED` and `PUBMED` maintaining explicit source boundaries and strict provenance tracing.

### Expanded Coverage
1. **Medical Category Coverage**: PASS. Successfully expanded to cover Anticoagulants (Warfarin), Antiplatelets (Clopidogrel), NSAIDs (Ibuprofen, Naproxen), Antibiotics (Erythromycin), Antidiabetics (Metformin), Antihypertensives (Lisinopril), Statins (Simvastatin, Atorvastatin), Antidepressants (Fluoxetine, Sertraline), Antiepileptics (Carbamazepine), and OTCs (Acetaminophen).
2. **DDI Coverage**: PASS. Now explicitly supports evaluating specific known combinations such as `Clopidogrel` + `Omeprazole` (CYP2C19 inhibition) and `Fluoxetine` + `MAOIs` (Serotonin Syndrome).
3. **ADE/Safety Coverage**: PASS. Contains specific authoritative warnings for hepatotoxicity, fetal toxicity, cardiovascular events, and serious dermatologic reactions (e.g. HLA-B*1502).

### Technical Quality Controls
- **Source Provenance**: PASS. Each chunk preserves `document_id`, `chunk_id`, `source`, `content_hash`, and generation `timestamp`.
- **Entity Alignment**: PASS. Embedded representations support the existing RxNorm deterministic canonicalization constraints.
- **Duplicate Control**: PASS. Hash-based collision detection prevented duplication of overlapping entities during generation.
- **Evidence Integrity**: PASS. Deterministic `sha256` hashing accurately records V2 content structure for downstream RAG eligibility gates.
- **Freshness Metadata**: PASS. Appropriately carried over from source representations.

### Application Validation
- **Retrieval Regression**: PASS. `HybridRetrievalEngine` effectively targets V2 chunks upon API request.
- **Real Live LLM & Multimodal Validation**: PASS. Expanded corpus successfully integrates into the established `api/v1/analyze` processing stream. Direct and Multimodal boundaries correctly hit V2 context.
- **Security & Prompt Poisoning Defenses**: PASS. Augmented corpus size does not weaken existing prompt injection detection bounds.
- **Controlled Abstention**: PASS. Out-of-bounds entity mappings trigger explicit abstention rather than hallucinating from the larger corpus.

### Research Isolation Audit
- **Research Medical Requests**: 0
- **Frozen Research Artifacts Modified**: NO
- **Track A Benchmark Altered**: NO

### Known Limitations
- The "Live" corpus remains a synthetic subset intended for application and integration testing. Real-world scaling requires robust vector-database indexing and incremental updates beyond static JSON parsing.
